DBV Technologies S.A.

1.2500.00Vol 15.79K1Y Perf -30.56%
Oct 4th, 2023 16:00 DELAYED
BID1.24 ASK1.32
Open1.26 Previous Close1.25
Pre-Market- After-Market-
 - -  - -%
Target Price
5.75 
Analyst Rating
Moderate Buy 2.00
Potential %
360.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     55.60
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
13.18 
Earnings Rating
Strong Sell
Market Cap240.63M 
Earnings Date
2nd Nov 2023
Alpha-0.02 Standard Deviation0.28
Beta1.19 

Today's Price Range

1.191.28

52W Range

1.082.37

5 Year PE Ratio Range

-1.10-3.30

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-5.30%
1 Month
-28.57%
3 Months
-31.69%
6 Months
-27.75%
1 Year
-30.56%
3 Years
-24.24%
5 Years
-93.47%
10 Years
-

TickerPriceChg.Chg.%
DBVT1.250.00000.00
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
7.80
7.90
0.01
0.02
-179.80
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
-
1.51K
1.49K
-
-
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.13-0.130.00
Q01 2023-0.25-0.1156.00
Q04 2022-0.23-0.230.00
Q03 2022-0.16-0.0943.75
Q02 2022-0.17-0.18-5.88
Q01 2022-0.47-0.1568.09
Q04 2021-0.32-0.1359.38
Q03 2021-0.29-0.2224.14
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.15-15.38Negative
12/2023 QR-0.16-14.29Negative
12/2023 FY-0.54-5.88Negative
12/2024 FY-0.52-10.64Negative
Next Report Date2nd Nov 2023
Estimated EPS Next Report-0.15
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume15.79K
Shares Outstanding192.50K
Shares Float66.89M
Trades Count190
Dollar Volume19.54K
Avg. Volume78.36K
Avg. Weekly Volume45.51K
Avg. Monthly Volume69.26K
Avg. Quarterly Volume120.32K

DBV Technologies S.A. (NASDAQ: DBVT) stock closed at 1.25 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 15.79K shares and market capitalization of 240.63M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 311 people. DBV Technologies S.A. CEO is Daniel Tasse.

The one-year performance of DBV Technologies S.A. stock is -30.56%, while year-to-date (YTD) performance is -18.3%. DBVT stock has a five-year performance of -93.47%. Its 52-week range is between 1.08 and 2.37, which gives DBVT stock a 52-week price range ratio of 13.18%

DBV Technologies S.A. currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 1.33, a price-to-sale (PS) ratio of 64.92, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -35.99%, a ROC of -40.93% and a ROE of -45.46%. The company’s profit margin is -%, its EBITDA margin is 1 487.80%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from DBV Technologies S.A., there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.15 for the next earnings report. DBV Technologies S.A.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for DBV Technologies S.A. is Moderate Buy (2), with a target price of $5.75, which is +360.00% compared to the current price. The earnings rating for DBV Technologies S.A. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DBV Technologies S.A. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DBV Technologies S.A. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.05, ATR14 : 0.09, CCI20 : -145.35, Chaikin Money Flow : -0.16, MACD : -0.07, Money Flow Index : 33.61, ROC : -12.59, RSI : 32.87, STOCH (14,3) : 18.72, STOCH RSI : 0.00, UO : 41.98, Williams %R : -81.28), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DBV Technologies S.A. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

DBV Technologies S.A.

DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The company focuses on discovering, developing, manufacturing, and commercializing treatments for severe allergies in the United States and other global markets. DBV's method of delivering biologically active compounds to the immune system is through self-administered and noninvasive products. The company also explores potential applications of its platform in vaccines and other immune diseases.

CEO: Daniel Tasse

Telephone: +33 155427878

Address: 177-181 avenue Pierre Brossolette, Montrouge 92120, , FR

Number of employees: 311

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

56%44%

Bearish Bullish

54%46%

 

News

Stocktwits